These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19010918)
1. Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats. Chauvin C; Philippeau JM; Hémont C; Hubert FX; Wittrant Y; Lamoureux F; Trinité B; Heymann D; Rédini F; Josien R Cancer Res; 2008 Nov; 68(22):9433-40. PubMed ID: 19010918 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma. Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yamashita T; Ishii S; Uede T Cancer Gene Ther; 2002 Sep; 9(9):747-55. PubMed ID: 12189524 [TBL] [Abstract][Full Text] [Related]
3. [Inducing specific antitumor effects on osteosarcoma by fused vaccine of rat dendritic cells]. Yu Z; Fan QY; Ma BA; Hao XB; Long H Ai Zheng; 2005 Mar; 24(3):285-91. PubMed ID: 15757528 [TBL] [Abstract][Full Text] [Related]
4. Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrier. del Rio ML; Cote-Sierra J; Rodriguez-Barbosa JI Transpl Int; 2011 May; 24(5):501-13. PubMed ID: 21276089 [TBL] [Abstract][Full Text] [Related]
6. Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims. Trinité B; Chauvin C; Pêche H; Voisine C; Heslan M; Josien R J Immunol; 2005 Aug; 175(4):2408-17. PubMed ID: 16081812 [TBL] [Abstract][Full Text] [Related]
7. Killer dendritic cells and their potential role in immunotherapy. Ullrich E; Chaput N; Zitvogel L Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624 [TBL] [Abstract][Full Text] [Related]
8. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells. Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551 [TBL] [Abstract][Full Text] [Related]
9. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer. Wesa AK; Storkus WJ Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028 [TBL] [Abstract][Full Text] [Related]
10. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
11. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347 [TBL] [Abstract][Full Text] [Related]
12. Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96. Goyos A; Cohen N; Gantress J; Robert J Eur J Immunol; 2004 Sep; 34(9):2449-58. PubMed ID: 15307177 [TBL] [Abstract][Full Text] [Related]
13. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg. Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486 [TBL] [Abstract][Full Text] [Related]
14. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response. Gauvrit A; Brandler S; Sapede-Peroz C; Boisgerault N; Tangy F; Gregoire M Cancer Res; 2008 Jun; 68(12):4882-92. PubMed ID: 18559536 [TBL] [Abstract][Full Text] [Related]
15. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. Qiu CH; Miyake Y; Kaise H; Kitamura H; Ohara O; Tanaka M J Immunol; 2009 Apr; 182(7):4127-36. PubMed ID: 19299710 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death. Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479 [TBL] [Abstract][Full Text] [Related]
17. Specific antitumor effects of tumor vaccine produced by electrofusion between osteosarcoma cell and dendritic cell in rats. Yu Z; Fan Q; Hao X; Long H Cell Mol Immunol; 2004 Dec; 1(6):454-60. PubMed ID: 16293215 [TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic tumor vaccine produced by electrofusion between osteosarcoma cell line and dendritic cells in the induction of antitumor immunity. Yu Z; Ma B; Zhou Y; Zhang M; Long H; Wang Y; Fan Q Cancer Invest; 2007; 25(7):535-41. PubMed ID: 17952746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]